---
title: 'Impact of Myc-Altered Pathology on Radiotherapy Efficacy Among Patients with
  Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by XXX: Impact
  of double hit pathology on RT efficacy'
date: '2024-11-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39549763/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20241117172403&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'CONCLUSIONS: Relapsed/refractory LBCL remains radioresponsive with 60-80%
  response rate to RT. While DHL pathology does not appear to influence RT response,
  its presence is associated with higher rates of local recurrence, suggesting it
  may be more ...'
disable_comments: true
---
CONCLUSIONS: Relapsed/refractory LBCL remains radioresponsive with 60-80% response rate to RT. While DHL pathology does not appear to influence RT response, its presence is associated with higher rates of local recurrence, suggesting it may be more ...